What is she best known for?
The fields of study she is best known for:
Maria Carmo-Fonseca mainly investigates Molecular biology, Cell biology, RNA splicing, snRNP and RNA.
Her research in Molecular biology intersects with topics in Gene expression, Ribonucleoprotein, Nucleolus, Transcription factories and Transcription.
Her studies in Cell biology integrate themes in fields like Heterogeneous ribonucleoprotein particle, Nuclear protein and Biochemistry.
Her RNA splicing study is concerned with the field of Genetics as a whole.
Her biological study spans a wide range of topics, including Splicing Factor U2AF and Coilin.
Her work carried out in the field of RNA brings together such families of science as Chromatin, Binding domain, Membrane and Messenger RNA.
Her most cited work include:
- Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells (602 citations)
- Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 snRNPs in coiled bodies (349 citations)
- To be or not to be in the nucleolus (342 citations)
What are the main themes of her work throughout her whole career to date?
Maria Carmo-Fonseca spends much of her time researching Cell biology, RNA splicing, Molecular biology, Genetics and RNA.
She usually deals with Cell biology and limits it to topics linked to Spliceosome and Precursor mRNA.
The RNA splicing study combines topics in areas such as Alternative splicing and Intron.
As a part of the same scientific study, Maria Carmo-Fonseca usually deals with the Molecular biology, concentrating on Nucleolus and frequently concerns with Small nucleolar RNA.
Her research investigates the connection between RNA and topics such as Transcription that intersect with issues in Gene expression.
Her study in Cell nucleus is interdisciplinary in nature, drawing from both Cajal body and Nuclear pore.
She most often published in these fields:
- Cell biology (45.54%)
- RNA splicing (34.16%)
- Molecular biology (31.68%)
What were the highlights of her more recent work (between 2016-2021)?
- Cell biology (45.54%)
- Induced pluripotent stem cell (5.94%)
- RNA splicing (34.16%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Cell biology, Induced pluripotent stem cell, RNA splicing, RNA and Transcription.
Her Cell biology study integrates concerns from other disciplines, such as Respiratory chain, Cell type and Smaug.
RNA splicing is a subfield of Gene that Maria Carmo-Fonseca tackles.
The RNA study combines topics in areas such as Messenger RNA, Computational biology and Intron.
The concepts of her Transcription study are interwoven with issues in Molecular biology and Genome instability.
Her Spliceosome study integrates concerns from other disciplines, such as Cytoplasm, Exon junction complex, snRNP, MRNA transport and Small nuclear ribonucleoprotein.
Between 2016 and 2021, her most popular works were:
- Deep intronic mutations and human disease. (148 citations)
- Distinctive Patterns of Transcription and RNA Processing for Human lincRNAs. (120 citations)
- RNA Polymerase II Phosphorylated on CTD Serine 5 Interacts with the Spliceosome during Co-transcriptional Splicing. (58 citations)
In her most recent research, the most cited papers focused on:
Maria Carmo-Fonseca focuses on Cell biology, RNA splicing, Stem cell, Induced pluripotent stem cell and Exon.
Her work on Cell biology is being expanded to include thematically relevant topics such as Nonsense-mediated decay.
Maria Carmo-Fonseca interconnects Polyadenylation and Intron in the investigation of issues within RNA splicing.
Her Exon study introduces a deeper knowledge of Genetics.
Her work on Chromatin and Transcription as part of general Gene study is frequently linked to RNA polymerase II, bridging the gap between disciplines.
Maria Carmo-Fonseca performs multidisciplinary studies into RNA polymerase II and Molecular biology in her work.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
